02877 SHINEWAY PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 3.71X | Oper Margin | 40.7% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 30.3% |
| Total Debt/Equity | 4.2% | Return on Equity | 11.8% |
| Price/Book | 0.90X | Return on Assets | 8.8% |
| (HKD 9.760) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 1,057.39 | 893.40 | 1,068.59 | 810.37 | 680.87 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +18.4 | -16.4 | +31.9 | +19.0 | +94.5 |
| Earnings Per Share (HKD) | 1.4 | 1.183 | 1.415 | 1.073 | 0.902 |
| Earnings Per Share Growth (%) | +18.4 | -16.4 | +31.9 | +19.0 | +94.9 |
| Dividend Per Share (HKD) | 0.505 | 0.581 | 0.471 | 0.383 | 0.470 |
| P/E* (X) | 6.97 | 8.25 | 6.90 | 9.10 | 10.83 |
| Yield (%) | 5.17 | 5.95 | 4.83 | 3.92 | 4.81 |
| Dividend Share (%) | 36.08 | 49.12 | 33.30 | 35.70 | 52.09 |
| Book NAV (HKD) | 10.851 | 9.602 | 9.376 | 8.653 | 8.728 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 3,135 | 3,778 | -17.0 | 4,517 |
| Operating Result | 1,269 | 1,146 | +10.7 | 1,240 |
| Profit Before Taxation | 1,269 | 1,146 | +10.7 | 1,240 |
| Taxation | 319.318 | 305.669 | +4.5 | 270.743 |
| Profit /( Loss) After Taxation | 949.948 | 840.052 | +13.1 | 969.51 |
| Net Profit | 949.948 | 840.052 | +13.1 | 969.51 |
| Earnings Per Share () | 1.3998 | 1.1827 | +18.4 | 1.4146 |
| Dividend Per Share () | 0.5050 | 0.5810 | -13.1 | 0.4710 |
| Announcement Date | 2026-03-27 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
